ai segmentation

Search

19.2.2024

MVision AI is delighted to announce that we have received our 2nd order for the Republic of Ireland from St. Luke’s Radiation Oncology Network (SLRON)

Finland, Helsinki, February 19, 2024 The contract for installing Contour+ Guideline Based AI Segmentation tool has been won through the public tender process and implies a three-year agreement for 5,000 scans per year. This order comes in quick succession following MVision AI's successful award of the tender from the Republic…

Press Releases

2.2.2024

World Cancer Day – Joining efforts for a better cancer care

World cancer day, celebrated on the 4th of February, was established more than 20 years ago. It represents an initiative of the Union for International Cancer Control (UICC) , the oldest and largest global membership organization dedicated to taking action on cancer. UICC has over 1150 member organizations in 172…

News

19.1.2024

Contour+ performance on Male Pelvis synthetic CTs

Results of MVision AI’s solutions scientific evaluation were presented at the previous ASTRO annual meeting. One of the posters included data from paired MRI and synthetic CT scans (MRCAT) of male pelvis and showed the accuracy and consistency of Contour+ models. The abstract was published in  Volume 117 Issue 2…

Articles

11.1.2024

The voice of customer experience: Dr. Giuseppe Sasso, New Zealand

Dr. Giuseppe Sasso is a Radiation Oncologist with extensive experience in the field, who has been using MVision AI for more than a year already, as an individual customer. He graduated from University of Naples where he also finished residency training 25 years ago. Since then, he has treated patients…

Articles

8.1.2024

Merging (Artificial) Intelligence and Ethics in Radiation Oncology – Why and How?

”Our future is a race between the growing power of technology and the wisdom with which we use it.” This statement of Stephen Hawking, the well known physicist, mathematician and visionary, summarizes very well the present challenges. A new technology, irrespective of its degree of complexity, makes an impact in…

Articles

8.1.2024

LEARN. PREVENT. SCREEN. CERVICAL CANCER CAN BECOME HISTORY.

January is Cervical Cancer Awareness Month, and these three core principles are emphasized during the 2024 campaign. Nowadays, cervical cancer is responsible for more than 300,000 deaths each year globally. Fortunately, we have the tools to prevent it, diagnose it early, and treat it efficiently in most cases. This is…

Articles

7.12.2023

AI-based auto-contouring – What to expect?

Time is money but it’s even more than that - time is life. Radiotherapy is one of the medical fields in which technological advances find a proper receptor. We find new ways to use outstanding computer capabilities to increase the quality of services and focus on the next steps to…

Articles

7.8.2023

The Importance of Guidelines and Standards in Radiotherapy

During the webinar, Jarkko discussed the critical role that guidelines and standards play in ensuring the safety and effectiveness of radiotherapy treatments. He shared insights on how MVision AI’s Guideline Based Segmentation solution drives and automates compliance with these guidelines and improves the overall quality of care for patients. …

Webinars and Videos

5.6.2023

Advancements in Breast Cancer Treatment: Highlights from the ESTRO 2023 Conference

The annual meeting of the European Society for Radiotherapy and Oncology (ESTRO) took place in Vienna from 12 to 15 May, gathering over 6000 professionals. More than 2500 abstracts on radiotherapy-related research projects were spread among 197 sessions. May was also cancer research month and international women’s health month. Since…

Articles

11.4.2023

Radiotherapy for Esophageal Cancer – The Challenge of a Difficult Site

More than half a million people are diagnosed each year with esophageal cancer. It is the 8th most common cancer type and places sixth regarding mortality[1]. Several factors influence the treatment decision with this cancer diagnosis, like the stage of the disease, the tumor site, the pathological type, and the…

Articles

23.3.2023

Press Release: MVision AI raises 5.4M€ to make same-day cancer treatment the new standard

HELSINKI, Finland - March 23, 2023 MVision AI raises 5.4M€ to make same-day cancer treatment the new standard MVision AI is the first cloud-based AI-powered radiotherapy planning solution for treating cancer. MVision uses artificial intelligence to automate cancer treatments with its unique automatic segmentation tool. The next-generation technology speeds up…

Press Releases

20.2.2023

Perspectives on the implementation of AI-based solutions for Radiation Oncology – Where are we?

One of the main characteristics of humans, compared to most other living creatures, is the ability of making tools. Progress has been linked to discoveries and the development of new devices. People have always tried to enhance their capabilities, and our days are not different. But how do we perceive…

Articles

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI